key: cord-0880373-aoo5yws8
authors: Horne, B. D.; Muhlestein, J. B.; May, H. T.; Le, V. T.; Bair, T. L.; Knowlton, K. U.; Anderson, J. L.
title: Association of Periodic Fasting with Lower Severity of COVID-19 Outcomes in the SARS-CoV-2 Pre-Vaccine Era: An Observational Cohort from the INSPIRE Registry
date: 2022-03-20
journal: nan
DOI: 10.1101/2022.03.17.22272577
sha: 14e6978cd0754b79bd888248badc7924e26b1120
doc_id: 880373
cord_uid: aoo5yws8

Objectives: Intermittent fasting boosts some mechanisms of host defense against infection while modulating the inflammatory response. Lower-frequency periodic fasting is associated with greater survival and lower risk of comorbidities that exacerbate COVID-19. This study evaluated the association of periodic fasting with COVID-19 severity and, secondarily, initial diagnosis of infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Design: Prospective longitudinal observational cohort study. Setting: Single-center secondary care facility in Salt Lake City, Utah, USA with follow-up across a 24-hospital integrated healthcare system. Participants: Patients enrolled in the INSPIRE registry in 2013-2020 were studied if they had SARS-CoV-2 testing in March 2020-February 2021 and either tested positive (N=205) for the primary outcome evaluation or had a positive or negative test result for evaluation of the secondary outcome (n=1,524). Interventions: No treatment assignments were made; individuals provided information about their personal practice and history of engaging in routine periodic fasting across their lifespan. Main outcome measures: The association of periodic fasting with a composite of mortality or hospitalization as the primary outcome was evaluated by Cox regression through February 2021 and multivariable adjustments considered 36 covariables in INSPIRE patients diagnosed with COVID-19. Secondary analysis evaluated the association of fasting with testing positive for SARS-CoV-2 in INSPIRE patients evaluated for COVID-19 (n=1,524). Results: Subjects engaging in periodic fasting (n=73, 35.6%) did so for 40.4{+/-}20.6 years (max: 81.9 years) prior to COVID-19 diagnosis. The composite outcome occurred in 11.0% of periodic fasters and 28.8% of non-fasters (p=0.013), with HR=0.61 (95% CI=0.42, 0.90) favoring fasting. Multivariable analyses confirmed this association. Other predictors of hospitalization/mortality were age, Hispanic ethnicity, prior MI, prior TIA, and renal failure, with trends for race, smoking, hyperlipidemia, coronary disease, diabetes, heart failure, and history of anxiety, but not alcohol use. In secondary analysis, COVID-19 was diagnosed in 14.3% of fasters and 13.0% of non-fasters (p=0.51). Conclusions: Routine periodic fasting was associated with a lower risk of hospitalization or mortality in patients with COVID-19. Fasting may be a complementary therapy to vaccination that could provide immune support and hyperinflammation control during and beyond the pandemic. Trial registration: clinicaltrials.gov, NCT02450006 (the INSPIRE registry)

Data Availability: The data underlying this article cannot be shared publicly due to United States privacy laws. The data will be shared contractually on reasonable request to the corresponding author.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ;  https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint

• During a period of energy restriction, fasting controls inflammation by dampening the cytokine cascade and it switches the metabolic source of energy from glucose to fats, including by increasing circulating free fatty acids such as linoleic acid.

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domains bind linoleic acid in pockets that, when bound, reduce spike protein affinity for the angiotensinconverting enzyme 2.

• Repeated fasting boosts basal levels of some parameters related to inflammation control and host defense against infections, including galectin-3, and it ameliorates insulin resistance and cardiovascular risks such that periodic fasting is associated with greater survival and lower risk of heart failure, coronary artery disease, and type 2 diabetes.

• This study evaluated the association of periodic fasting with severity of coronavirus disease 2019 and with initial infection with SARS-CoV-2 in a population where a substantial proportion of people routinely engage in periodic dry or water-only fasting, primarily for religious purposes.

• This observational epidemiologic study found that routine low-frequency periodic fasting for an average of >40 years was associated with a lower risk of a composite of hospitalization or mortality after COVID-19 diagnosis, suggesting that fasting deserves further investigation as a complementary approach along with vaccines for reducing COVID-19 severity.

• The study also found no association of periodic fasting with the onset of SARS-CoV-2 infection.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2022 , prior TIA, and renal failure, with trends for race, smoking, hyperlipidemia, coronary disease, diabetes, heart failure, and history of anxiety, but not alcohol use. In secondary analysis, COVID-19 was diagnosed in 14.3% of fasters and 13.0% of non-fasters (p=0.51).

Conclusions: Routine periodic fasting was associated with a lower risk of hospitalization or mortality in patients with COVID-19. Fasting may be a complementary therapy to vaccination that could provide immune support and hyperinflammation control during and beyond the pandemic.

Trial registration: clinicaltrials.gov, NCT02450006 (the INSPIRE registry)

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2022.

Fasting modifies energy utilization by consuming glucose and glycogen, inducing gluconeogenesis, and subsequently activating ketogenesis. (1) (2) (3) In the switch to ketosis during fasting, circulating levels of fatty acids increase,(2,3) including linoleic acid.(4) Intriguingly, linoleic acid tightly binds to the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 . (5) The attachment of linoleic acid to the spike reduces the affinity of SARS-CoV-2 for the angiotensin-converting enzyme 2 (ACE2).(5) An acute rise in linoleic acid while a person is fasting, thus, provides a direct mechanism for fasting to acutely reduce the severity of COVID-19.

In terms of chronic protection from severe outcomes of infection, the multi-faceted protein galectin-3 was increased, independent of weight change, by low-frequency intermittent fasting in the 6-month WONDERFUL trial.(6) Galectin-3 modulates inflammation with proinflammatory actions during acute infection and anti-inflammatory functions when infection resolves,(7) it minimizes risk from chronic metabolic disorders (e.g., diabetes), (8) and is elevated in patients with diabetes and heart failure (HF),(9) perhaps as a protective mechanism to reduce risk [e.g., the anti-diabetes medication canagliflozin also increased galectin-3 (10) ]. Importantly, galectin-3 directly binds to a wide variety of pathogens,(7) activates the innate immune system, (7) impacts respiratory infections,(11) increases expression of human genes encoding proteins with antiviral capacities, (12) and inhibits viral replication. (12) Given the wide array of pathogens affected by galectin-3,(7) it may also limit SARS-CoV-2 infection. The chronic increase of galectin-3 by intermittent fasting may,(6) thus, provide a mechanistic link in which long-term participation in fasting could reduce COVID-19 severity.

Previously, routine periodic fasting was associated with lower risk of coronary artery disease (CAD),(13) lower risk of type 2 diabetes,(14) and-in patients with a >42-year history of . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (19, 20) ] may indirectly reduce COVID-19 severity, providing a possible third biological mechanism for fasting-induced protection from severe COVID-19 outcomes.

Due to these direct and indirect impacts of fasting on infectious disease outcomes, it is hypothesized that periodic fasting is associated with lower COVID-19 severity in people infected by SARS-CoV-2. The aims this study were to evaluate the association of periodic fasting with COVID-19 outcomes in people testing positive for SARS-CoV-2 and, secondarily, to examine the risk for SARS-CoV-2 positivity in people initially free of infection.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

Objectives. The primary objective of this study was to test whether periodic fasting is associated with the severe COVID-19 outcomes of hospitalization and mortality after subjects were diagnosed with COVID-19. A secondary objective was to test whether periodic fasting predicts the onset of COVID-19. This prospective observational cohort study evaluated patients who previously underwent cardiac catheterization and completed a sociobehavioral survey regarding periodic fasting behavior, education, income, marital status, exercise, work, race, ethnicity, alcohol intake, and sleep behaviors. The survey was previously published. (15) No subject was randomized in this study, but instead the long-term databasing and Figure S1 for a flow chart of included and excluded patients; see Supplemental Table S1 for basic characteristics of patients not included in this study), 5,795 patients (67.1%) completed the INSPIRE survey and . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (13, 15) However, because in prior work ≈40% of LDS Church members reported that they engage in periodic fasting and religious preference did not confound the effect of fasting, (13, 15) and because the systematically-shared health-related behaviors like not smoking and not drinking alcohol were measured in this study, religious preference per se was not evaluated here.

Data elements for race, ethnicity, income, education, marital status, employment status, physical exercise (e.g., swimming, jogging, aerobics, football, tennis, gym workout), cycling, walking, and alcohol use were also drawn from the INSPIRE survey. Age, sex, body mass index (BMI), smoking (current or past), other cardiac risk factors, and comorbidities were extracted . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Cox regression was used to compute hazard ratios (HR) and 95% confidence intervals (CI) for the association of periodic fasting with the composite hospitalization/mortality endpoint. The Wald approximation to the chi-square test was used to assess statistical significance in survival . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint analyses. Kaplan-Meier survival curves were also drawn to graphically demonstrate the survival associations.

Multivariable Cox modeling evaluated periodic fasting with adjustments for 36 covariables (see Table 1 for all covariables). Cox regressions were performed for each covariable and bivariable models entered periodic fasting with a single covariable. Because of the number of hospitalization and mortality events observed (46 events), Cox analyses were limited to a maximum of 4 variables per model. Variables with three or four variables entered periodic fasting and age along with one or two others to assess significance and confounding. A confounding effect of a covariable was defined as a change of >10% of the beta-coefficient of periodic fasting in Cox regression.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

Baseline characteristics of N=205 patients diagnosed with COVID-19 are presented in Table 1 (see below for details of the 1,524 tested for COVID -19) . Subjects engaging in periodic fasting (35.6%) did so for 40.4±20.6 years (max: 81.9 years), with 36.7±20.4 of those years being prior to enrollment in the INSPIRE registry and 3.7±2.9 years being between enrollment and when the subjects tested positive for SARS-CoV-2.

In the N=205 patients with COVID-19, 11.0% of fasters and 28.8% of non-fasters had hospitalization/mortality ( Figure 1 ). This constituted a total of 46 composite study events, or 40 hospitalizations without death, 4 hospitalizations ending in death, and 2 deaths without hospitalization.

The association of periodic fasting with the composite endpoint had HR=0.61 (CI=0.42, 0.90; p=0.013).

Fasting remained significant in all multivariable analyses (Table 2) , with a range of HR=0.61-0.65 depending on the covariables that were entered (p=0.015-0.036). Results for periodic fasting were similar in subjects <65 years and ≥65 years of age (Figure 2) , although splitting the population into the two subgroups (n=104 and n=101, respectively) reduced the statistical significance in both age groups.

Covariables that were associated with the composite outcome in models that also entered periodic fasting included: age (HR=1. 32 HR=5.025, p=0 .008). These covariable associations became less significant when age was added to models, with most of the covariables listed above having p>0.05 in 3-variable models that also entered age and periodic fasting. In . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint 4-variable models entering periodic fasting, age, Hispanic ethnicity, and one comorbidity, the only comorbidities retaining significance at p≤0.05 were MI history, TIA history, and renal failure history (see Table 2 footnotes for further information). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Severe Outcomes of COVID-19. The degree to which COVID-19 resulted in hospitalization and mortality throughout the world varied substantially during the pandemic. This is due to many health, medical, biological, and healthcare issues, as well as social and political challenges, that resulted in a complex patchwork of differences in risk of hospitalization and mortality across populations. Some of the factors involved in that variation include a population's age distribution, its racial and ethnic composition, cardiovascular risk factor prevalences, and the distribution of comorbidities. (19, 20) Various mitigating factors specific to populations may also have lowered the severity of COVID-19.

Prior to SARS-CoV-2 vaccines, Utah and Alaska were the only US states with a COVID-19 case fatality rate <1% (both were ≈0.5%).(21) Alaska has the 49 th largest state population and before December 2021 had ≈47 th highest number of COVID-19 cases.(21) Its low case fatality could be anticipated because it is a geographic isolate to which COVID-19 arrived relatively late. Alaska's public health officials had time to prepare and execute an aggressive mitigation program that delayed widespread infection. Further, Alaska has the lowest number of nursing home beds in the US (at ≈700 beds, versus Utah's ≈8,500 beds). (22) Utah has the 30 th largest state population and before December 2021 had ≈28 th highest case count, (21) and shares some characteristics with Alaska that are relevant to . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint COVID-19 severity: Utah has the lowest median age in the US (Alaska has the second lowest) and is ranked as the state with the 4 th lowest rate of coronary heart disease (Alaska is ranked 8 th lowest).(23) A low case fatality rate in Utah could also have occurred because the state has the lowest smoking rate in the US, has a limited racial/ethnic diversity (39 th highest proportion of minorities), and had various healthcare system efforts that may have limited the severity of cases. Finally, Utah has the lowest per capita ethanol consumption in the US that may have limited the spread of COVID-19 at bars and other social locales, but a connection of alcohol to COVID-19 severity is unconfirmed.

Given those characteristics of the Utah population, when survival analyses herein adjusted for age, smoking, alcohol, race, ethnicity, CAD history, MI history, HF history, and other factors, periodic fasting remained an independent predictor of a lower risk of hospitalization or mortality. Because >60% of Utah residents are members of the LDS Church, routine periodic fasting is a common practice in the state. In this and previous studies at Intermountain, 27%-36% of all patients reported routinely engaging in periodic fasting, (13) (14) (15) and had done so for more than 4 decades on average (with age averaging >60 years). (15) Although these data suggest that only about one third of the Utah population engages routinely in periodic fasting, this is substantially higher than in other US states and may have contributed to the low COVID-19 case fatality rate for the state.

Periodic fasting was previously reported to be associated with lower mortality and lower HF incidence in a cohort of almost 2,000 patients.(15) A trend toward lower MI incidence was also found in that study.(15) Further, periodic fasting was associated with a lower risk of CAD and a lower risk of diabetes in cross-sectional studies. (13, 14) In the present study, in addition to the association of periodic fasting with a lower risk of hospitalization or mortality, various factors including many comorbidities were associated with a greater risk of hospitalization or mortality. These findings support published predictors of COVID-19 severity, (19, 20) and extends the list by adding routine fasting as a predictor of lower COVID-19 severity.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Very frequent intermittent fasting such as alternate-day fasting or uninterrupted multiple-day fasting is challenging. Even lower frequency or shorter duration fasting [e.g., 16-hour time-restricted eating (18) or 24-hour once-per-week fasting (31) ] over a long period of time (i.e., years/decades) may prevent chronic disease onset or reduce the severity of existing chronic diseases (13) (14) (15) and, thus, prepare the body to prevent severe COVID-19 outcomes. (26) This may occur as fasting prevents or treats morbidities (13) (14) (15) 30, 31) that increase the risk of severe COVID-19 outcomes, such as CAD, MI, HF, and diabetes. (19, 20) A variety of mechanisms may be involved in the long-term prevention and . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint treatment of those diseases (which mechanisms are beyond the scope of this study), (4, 6, (16) (17) (18) 26, (30) (31) (32) (33) (34) (35) ) and, as a preventive health practice, periodic fasting may indirectly prevent severe COVID-19 by its long-term impacts on those disease mechanisms and comorbidities. (25, 26, 36) Finally, a periodic fasting lifestyle may condition the body by elevating basal levels of key physiological parameters in preparation for insults such as infection. A randomized human study of lowfrequency (once-per-week) 24-hour water-only intermittent fasting showed that fasting increased basal galectin-3 level over a moderate-term (six months).(6) Galectin-3 is integrally involved in host defense to infectious diseases. (7, 11, 12) Further, galectin-3 stimulates anti-inflammatory effects by modulating NF-κB and the NLRP3 inflammasome,(8) which should inhibit the hyperinflammation associated with COVID-19. The routine practice of once-per-month fasting for >40 years that is reported here is lower frequency fasting over a longer term and may have conditioned the body by elevating basal galectin-3 and optimizing basal levels of other factors that aided in preventing severe complications of COVID-19.

Further study is needed of how fasting may impact the human immune system.

This study is potentially limited by the observational nature in which subjects engaging in periodic fasting were not randomized to the behavior. Incomplete adjustment for important confounders or failure to measure some confounders may have limited the ability to correctly assign risk to the variables under study. However, 36 covariables were evaluated and none of them substantially modified the association of periodic fasting with hospitalization/mortality, including smoking and others that may share some covariation with periodic fasting in the study population.

Further, many of the factors that may be systematically shared in the Utah population (e.g., not smoking, not drinking alcohol, being married) were shared by both those who engaged in fasting and those who did not because fewer than half of LDS Church members report that they engage in periodic fasting. (13, 15) Consequently, confounding from systematically shared religion-related characteristics is . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint less of an issue for this study than may be commonly assumed. Additionally, adjustment for variables such as smoking, alcohol use, marital status, and other factors corrected for shared health-related characteristics that could confound the association of periodic fasting with study outcomes.

The case fatality rate in the US was around 3% prior to the advent of SARS-CoV-2 vaccines, (21) and this study's mortality rate was similar: 6 of 205 subjects (2.93%) died. This partly reflects that this population was a higher risk group than the general population due to the prevalence of morbidities, older age, and existence of cardiovascular conditions requiring medical care. Thus, the findings of this study may not generalize to the overall population and interpretation should be made with caution. As with all medical interventions, assessment of the risks and not just the benefits of intermittent fasting should be made when considering its use, including for people with chronic diseases.(37)

Conclusions. Routine periodic fasting was associated with a lower risk of hospitalization or mortality in patients with COVID-19. While fasting is not a panacea or a quick fix for health problems, low-frequency fasting improves cardiometabolic health even without significant weight loss, (18, 31) and multiple biological mechanisms (4) (5) (6) (7) (8) 11, 12, (24) (25) (26) (27) (28) 30) and epidemiologic results (13) (14) (15) 19, 20) support the idea that consistent fasting may limit COVID-19 severity. Fasting may do so via acute but temporary physiological changes during energy deprivation and by persistent modification of basal physiological norms and reduction of chronic disease risks across repeated fasting episodes. The primary mechanisms may include hyperinflammation control and strengthening of some immunity pathways.

Sustainable intermittent fasting regimens deserve further investigation for potential short-and long-term preventive or therapeutic use as a complementary therapy to vaccines to reduce COVID-19 severity, both during the pandemic and post-pandemic since repeat vaccinations cannot be performed every few months indefinitely for the entire world and vaccine access is limited in many nations.

Investigations of the effect of fasting on long-COVID-19 should be included in new studies that are conducted.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. who engaged in periodic fasting compared to patients who did not, in strata defined by: A) age <65 years (p=0.07, n=104), and B) age ≥65 years (p=0.09, n=101).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint

Hormone-fuel interrelationships during fasting

Gluconeogenesis and its disorders in man

Energy Metabolism in Feasting and Fasting

Pilot study of novel intermittent fasting effects on metabolomic and trimethylamine noxide changes during 24-hour water-only fasting in the FEELGOOD Trial

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

Intermittent fasting and changes in galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjects

The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Galectin-3: an emerging all-out player in metabolic disorders and their complications

Galectin-3: a marker of cardiac fibrosis predicts incident heart failure in the community

Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes

The role of galectins in virus infection-A systematic literature review

Antiviral activity of aloeemodin against influenza A virus via galectin-3 up-regulation

for the Intermountain Heart Collaborative Study Group. Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography

Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization

Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences

Renin, aldosterone and glucagon in the natriuresis of fasting

Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes

Effect of heart failure on the outcome of COVID-19-A meta analysis and systematic review

Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis

An interactive web-based dashboard to track COVID-19 in real time

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2021 update: A report from the American Heart Association

Fasting increases microbiome-based colonization resistance and reduces host inflammatory responses during an enteric bacterial infection

Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response

COVID-19 and obesity: fighting two pandemics with intermittent fasting

Fasting-induced FOXO4 blunts human CD4 + T helper cell responsiveness

Identification and validation of nutrient state-dependent serum protein mediators of human CD4 + T cell responsiveness

Clinical criteria for COVID-19

Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial

Randomized controlled trial of once-per-week intermittent fasting for health improvement: The WONDERFUL Trial

Epidemiology of heart failure

Nutrient sensing, signaling and ageing: The role of IGF-1 and mTOR in ageing and age-related disease

The GH/IGF-1 axis in chronic heart failure

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2022. ; https://doi.org/10.1101/2022.03.17.22272577 doi: medRxiv preprint